Protein synthesis inhibitor-mediated stability of adenomatous polyposis coli mRNA levels in HCT-116 colon cancer cells

International Journal of Oncology

Volumn 14, Issue 6, 1999, Pages 1045-1048

  Jaiswal, Aruna S ^a   Narayan, Satya ^a,b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Adenomatous polyposis coli (APC) gene expression; Colon cancer; Cycloheximide; mRNA stability; Transcription

Indexed keywords

APC PROTEIN; CYCLOHEXIMIDE; CYTOSKELETON PROTEIN; MESSENGER RNA; PROTEIN SYNTHESIS INHIBITOR; TUMOR PROTEIN;

ARTICLE; BIOSYNTHESIS; CELL CULTURE; COLON TUMOR; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; TUMOR SUPPRESSOR GENE;

ADENOMATOUS POLYPOSIS COLI PROTEIN; COLONIC NEOPLASMS; CYCLOHEXIMIDE; CYTOSKELETAL PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, APC; HUMANS; NEOPLASM PROTEINS; PROTEIN SYNTHESIS INHIBITORS; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0033142115     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.14.6.1045     Document Type: Article

References (33)

1. Kinzler KW and Vogelstein B: Lessons from hereditary colorectal cancer. Cell 87: 159-170, 1996.
2. White RL: Colon cancer: molecular biology of the APC protein. Pathol Biol 45: 240-244, 1997.
3. Munemitsu S, Souza B, Muller O, Albert I, Rubinfeld B and Polakis P: The APC gene product associates with microtubules in vivo and promotes their assembly in vitro. Cancer Res 54: 3676-3681, 1994.
4. Smith KJ, Levy DB, Maupin P, Pollard TD, Vogelstein B and Kinzler KW: Wild-type but not mutant APC associates with the microtubule cytoskeleton. Cancer Res 54: 3672-3675, 1994.
5. Barth AI, Pollack AL, Altschuler Y, Mostov KE and Nelson WJ: NH2-terminal deletion of β-catenin results in stable colocalization of mutant β-catenin with adenomatous polyposis coli protein and altered MDCK cell adhesion. J Cell Biol 136: 693-706, 1997.
6. Su LK, Burrell M, Hill DE, Gyuris J, Brent R, Wiltshire R, Trent J, Vogelstein B and Kinzler KW: APC binds to the novel protein EB1. Cancer Res 55: 2972-2977, 1995.
7. Matsuminc A, Ogai A, Senda T, Okumura N, Satoh K, Baeg GH, Kawahara T, Kobayashi S, Okada M, Toyoshima K and Akiyama T: Binding of APC to the human homolog of the Drosophila discs large tumor suppressor protein. Science 272: 1020-1023, 1996.
8. -/- colon carcinoma. Science 275: 1784-1787, 1997.
9. Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B and Kinzler KW: Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC. Science 275: 1787-1790, 1997.
10. Rubinfeld B, Robbins P, El-Gamil M, Albert I, Porfiri E and Polakis P: Stabilization of β-catenin by genetic defects in melanoma cell lines. Science 275: 1790-1792, 1997.
11. Goyette MC, Cho C, Fasching CL, Levy DB, Kinzler KW, Paraskewa C, Vogelstein B and Stanbridge EJ: Progression of colorectal cancer is associated with multiple tumor suppressor gene defects but inhibition of any single defect via chromosome transfer. Mol Cell Biol 12: 1387-1395, 1992.
12. Groden J, Joslyn G, Samowitz W, Jones D, Bhattacharyya N, Spirio L, Thliveris A, Robertson M, Egan S, Meuth M and White R: Response of colon cancer cell lines to the introduction of APC, a colon-specific tumor suppressor gene. Cancer Res 5: 1531-1539, 1995.
13. Hargest R and Williamson R: Expression of the APC gene after transfection into a colonic cancer cell line. Gut 37: 826-829, 1995.
14. 1 to S phase. EMBO J 14: 5618-5625, 1995.
15. Morin PJ, Vogelstein B and Kinzler KW: Apoptosis and APC in colorectal tumorgenesis. Proc Natl Acad Sci USA 93: 7950-7954, 1996.
16. Narayan S and Jaiswal AS: Activation of adenomatous polyposis coli (APC) gene expression by the DNA-alkylating agent N-methyl-N′-nitro-N-nitrosoguanidine requires p53. J Biol Chem 272: 30619-30622, 1997.
17. Jaiswal AS and Narayan S: Protein synthesis and transcriptional inhibitors control N-methyl-N′-nitro-N-nitrosoguanidine-induced levels of APC mRNA in a p53-dependent manner. Int J Oncol 13: 733-740, 1998.
18. Hershey JWB: Transcriptional control in mammalian cells. Ann Rev Biochem 62: 121-138, 1991.
19. Linial M, Gunderson N and Groudine M: Enhanced transcription of c-myc in bursal lymphoma cells requires continuous protein synthesis. Science 220: 1126-1132, 1985.
20. Lau LF and Nathans D: Expression of a set of growth-related immediate early genes in BALB/c 3T3 cells: coordinate regulation with c-fos or c-myc. Proc Natl Acad Sci USA 84: 1182-1186, 1987.
21. Almendral JM, Sommer D, MacDonald-Bravo H, Burckhardt J, Perera J and Bravo R: Complexity of the early genetic response to growth factors in mouse fibroblasts. Mol Cell Biol 8: 2140-2148, 1988.
22. Yeilding NM, Procopio WN, Rehman MT and Lee WMF: c-myc mRNA is down-regulated during myogenic differentiation by accelerated decay that depends on translation of regulatory coding elements. J Biol Chem 273: 15749-15757, 1998.
23. Kinzler KW, Nilbert MC, Su LK, Vogelstein B, Bryan TM, Levy DB, Smith KJ, Preisinger AC, Hedge P, McKechnie D, Finniear R, Markham A, Groffen J, Boguski MS, Altschul SF, Horii AK, Ando H, Miyoshi Y, Nishisho I and Nakamura Y: Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science 253: 665-669, 1991.
24. Elder PK, Schmidt LJ, Ono T and Getz MJ: Specific stimulation of actin gene transcription by epidermal growth factor and cycloheximide. Proc Natl Acad Sci USA 81: 7476-7480, 1984.
25. Woloschak GE, Felcher P and Chang-Liu CM: Combined effects of ionizing radiation and cycloheximide on gene expression. Mol Carcinog 13: 44-49, 1995.
26. Voelkerding KV, Steffen DW, Zaidi SHE and Malter JS: Post-transcriptional regulation of the p53 tumor suppressor gene during growth-induction of human peripheral blood mononuclear cells. Oncogene 10: 515-521, 1995.
27. Ross J: mRNA stability in mammalian cells. Microbiol Rev 59: 423-450, 1995.
28. Ross J: A hypothesis to explain why translation inhibitors stabilize mRNAs in mammalian cells: mRNA stability and mitosis. BioEssays 19: 527-529, 1997.
29. Bernstein P, Peltz SW and Ross J: The poly(A)-poly(A)-binding protein complex is a major determinant of mRNA stability in vitro. Mol Cell Biol 9: 659-670, 1989.
30. Marzluff WF and Pandey NB: Multiple regulatory steps control histone mRNA concentrations. Trends Biochem Sci 13: 49-52, 1988.
31. Fort P, Rech J, Vie A, Piechaczyk M, Bonnieu A, Leanteur P and Blanchard JM: Regulation of c-fos gene expression in hamster fibroblasts: initiation and elongation of transcription and mRNA degradation. Nucleic Acids Res 15: 5657-5667, 1987.
32. Carter DA: Up-regulation of β1-adrenoceptor messenger ribonucleic acid in the rat pineal gland; nocturnally, through a β-adrenoceptor-linked mechanism, and in vitro through a novel post-transcriptional mechanism activated by specific protein synthesis inhibitors. Endocrinology 133: 2263-2268, 1993.
33. Oguchi SA, Weisz A and Esumi H: Enhancement of inducible-type NO synthase gene transcription by protein synthesis inhibitors: activation of an intracellular signal transduction pathway by low concentrations of cycloheximide. FEBS Lett 33: 326-330, 1994.